Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: SVY

The Photovoltaic market in Europe was valued at US$ 45.57 billion in 2019 and is projected to reach US$ 177.58 billion by 2027; it is expected to grow at a CAGR of 18.5% from 2020-2027


NEW YORK, May 22, 2020 /PRNewswire/ --

Photovoltaic Market to 2027- Covid-19 Impact and Europe Analysis by Application (Residential Applications, Commercial, Utility Applications); Type (Organic Components, Inorganic Components); Component (Cells, Optics, Trackers); and Country

Read the full report: https://www.reportlinker.com/p05894545/?utm_source=PRN

The Photovoltaic market in Europe was valued at US$ 45.57 billion in 2019 and is projected to reach US$ 177.58 billion by 2027; it is expected to grow at a CAGR of 18.5% from 2020-2027. The market in Europe comprises several developing economies such as Germany, France, Italy, the UK, and Russia. The solar power generation facilities in the European countries are well-established, and the government is constantly focusing on energy generation from renewable energy sources such as sun and wind. This factor is projected to boost the photovoltaic market in the European countries. The photovoltaic effect includes the creation of voltage or electrical current by exposure to light. Therefore, the demand for photovoltaic technology has surged with the rising number of solar power plants in the European countries such as Germany, France, Italy, and the UK. The majority of photovoltaic modules in the European countries are used to generate power connected to an electricity grid which is likely to drive the European photovoltaic market
On the basis of type, inorganic components segment led the photovoltaic market with a decent market share.The inorganic materials exhibit solar radiation-resistance, which is important for space applications like satellites and space station.

The technology used for the manufacture of photovoltaic solar cells is mainly silicon-based, which is an inorganic material.
Overall size of the European photovoltaic market has been derived using primary and secondary sources.The research process begins with exhaustive secondary research using internal and external sources to obtain qualitative and quantitative information related to the European photovoltaic market.

It also provides an overview and forecast for the photovoltaic based on all segmentation provided with respect to the European region.Additionally, primary interviews were conducted with industry participants and commentators in order to validate and analyze the data.

The participants who take part in such a process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, and external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the European photovoltaic industry. Mitsubishi Electric Corporation, Panasonic Corporation, and Kaneka Corporation are among the key players present in the European photovoltaic market.

Read the full report: https://www.reportlinker.com/p05894545/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 07:35
Arrowhead Pharmaceuticals, Inc. announced today that it has dosed the first subjects in a Phase 1/2a clinical trial (NCT06209177) of ARO-CFB, the company's investigational RNA interference (RNAi) therapeutic, in up to 66 healthy volunteers and...

at 07:35
Fortive Corporation ("Fortive") today announced financial results for the first quarter of 2024. For the first quarter, net earnings were $207 million. For the same period, adjusted net earnings were $295 million, which excludes the $63 million...

at 07:20
Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza (H5N1) virus, considered to be potential future pandemic threatStudy will assess monovalent vaccine candidate, encoding an...

at 07:20
CureVac N.V. ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger...

at 07:05
Healthcare Services Group, Inc. today reported results for the three months ended March 31, 2024. Ted Wahl, Chief Executive Officer, stated, "Our team delivered strong first quarter results, building on our positive momentum in 2023. During the...

at 07:05
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. , today announced that positive results from the Phase 3 oral zoliflodacin trial will be highlighted in an oral presentation given by the Global Antibiotic Research & Development...



News published on and distributed by: